Literature DB >> 32504019

The coronavirus outbreak could make it quicker and easier to trial drugs.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Business; Drug discovery; Industry; SARS-CoV-2

Mesh:

Substances:

Year:  2020        PMID: 32504019     DOI: 10.1038/d41586-020-01524-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Responsible innovation in synthetic biology in response to COVID-19: the role of data positionality.

Authors:  Koen Bruynseels
Journal:  Ethics Inf Technol       Date:  2020-10-26

Review 2.  [International publication activity during the COVID-19 pandemic].

Authors:  Stephanie Strobl; Wilfried Roth
Journal:  Pathologe       Date:  2021-01-12       Impact factor: 0.973

3.  Stakeholder Perspectives on Barriers and Facilitators for the Adoption of Virtual Clinical Trials: Qualitative Study.

Authors:  Romée Melanie Helena Coert; James Kenneth Timmis; André Boorsma; Wilrike J Pasman
Journal:  J Med Internet Res       Date:  2021-07-06       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.